This is a phase II trial of combination therapy of pembrolizumab and lenvatinib in patients with locally advanced or metastatic cervical cancer that had failed…

Cervical CancerMetastatic Cervical Cancer

~Estimated

~$10 – $6,250

Georgetown UniversityNCT04865887

Phase 2

A Multicenter Phase 2 Study to Evaluate Efficacy and Safety of PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer.

This Phase 2 study will evaluate the efficacy and safety of PRGN-2009 in combination with pembrolizumab in patients with pembrolizumab-resistant recurrent or m…

Cervical CancerHPV-Related CarcinomaHPV-Related Malignancy+2 more

~Estimated

~$10 – $8,750

Precigen, IncNCT06157151